Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry

Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry

0 Ungluers have Faved this Work
This Special Issue highlights the most recent research on depression, anxiety and dementia, with attention to comorbidity in a range of diseases. The symptoms of depression, anxiety and dementia are the most common comorbid manifestations present in patients suffering from neurodegenerative and psychiatric diseases. Together, these illnesses constitute an extremely complex and challenging research field due to their inherent multifactorial causative factors, heterogeneous pathogenesis, and mental and behavioral manifestations. This Special Issue covers laboratory, clinical and statistical studies on the crosstalk between depression, anxiety, dementia, Alzheimer’s disease, multiple sclerosis, schizophrenia, diabetes mellitus, Down’s syndrome, and/or compulsive disorders. It contains contributions from 71 authors, has been reviewed by 25 referees, and edited by three academic editors and one managing editor.

This book is included in DOAB.

Why read this book? Have your say.

You must be logged in to comment.

Rights Information

Are you the author or publisher of this work? If so, you can claim it as yours by registering as an rights holder.


This work has been downloaded 26 times via ebook links.
  1. 26 - pdf (CC BY) at


  • Aging
  • Alzheimer’s disease
  • Angiogenesis
  • Animal-Assisted Intervention
  • antioxidant
  • Anxiety
  • arterial properties
  • behavioral and psychological symptoms of dementia
  • biomarker
  • cerebral blood flow
  • Clinical & internal medicine
  • clinical trials
  • Cognition
  • Default Mode Network
  • Dementia
  • Depression
  • diabetes
  • Diabetes Mellitus
  • disability level
  • Down’s syndrome
  • drug response monitoring
  • dyslipidemias
  • executive control network
  • FFAR4
  • G protein-coupled receptors
  • gender medicine
  • GPR120
  • healthy life expectancy (HALE)
  • HPA axis
  • HPG axis
  • Hypertension
  • Inositol
  • insulin signaling
  • Kiss1 receptor
  • Kisspeptin
  • late-life depression
  • LC-MS/MS
  • Lipid
  • Locomotion
  • long-chain fatty acids
  • longitudinal study
  • Major Depressive Disorder
  • medicine
  • Meta-analysis
  • morbidity/mortality paradox
  • Mortality
  • multiple reaction monitoring
  • Multiple Sclerosis
  • neurodegenerative disease
  • Neurodegenerative disorders
  • neuroimaging
  • Nucleus Accumbens
  • nutraceutical
  • nutritional psychiatry
  • Omega-3
  • Oxidative Stress
  • personalized medicine
  • pet-robot intervention
  • plasma protein biomarker
  • polyunsaturated fatty acids
  • post-stroke depression
  • Psilocybin
  • psychiatric disease
  • redox
  • resting-state functional magnetic resonance imaging
  • salience network
  • Schizophrenia
  • Stroke
  • systematic review
  • systolic blood pressure
  • type 2


DOI: 10.3390/books978-3-0365-4002-3


edition cover


Copy/paste this into your site: